Differential inflammatory activation of IL-6 (-/-) astrocytes

被引:18
作者
Bolin, LM
Zhaung, A
Strychkarska-Orczyk, I
Nelson, E
Huang, I
Malit, M
Nguyen, Q
机构
[1] Parkinsons Inst, Sunnyvale, CA 94089 USA
[2] Bio Rad Labs Inc, Hercules, CA 94547 USA
关键词
reactive glia; cytokines; chemokines; lipopolysaccharide; inflammatory cascade;
D O I
10.1016/j.cyto.2004.11.007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
IL-6 is a major immunomodulatory cytokine with neuroprotective activity. The absence of interleukin-6 (IL-6) results in increased vulnerability of dopaminergic neurons to the neurotoxicant, MPTP, and a compromised reactive microgliosis. To determine how astroeliosis may contribute to nigrostriatal degeneration in IL-6 (-/-) mice, the inflammatory profiles of astrocytes of IL-6 genotype were compared. Fourteen cytokines and four chemokines were simultaneously assayed in the supernatants of LPS-stimulated primary astrocyte cultures. In a time course of 6, 18 and 48 h and LPS stimulations of 0, 0. 1, 1, 10 and 100 ng/ml, IL-6 (-/-) astrocytes secreted significantly greater amounts of the pro-inflatmnatory cytokines IL-1 alpha, IL-1 beta and TNF alpha than did IL-6 (+/+) cells. Elevated levels of IL-10 and IL-12p40 were only detected at 48 h post-stimulation with greater IL-10 in IL-6 (-/-) supernatants and greater IL-12p40 in IL-6 (+/+) supernatants. IL-6 (+/+) astrocytes produced more G-CSF and GM-CSF when compared with IL-6 (-/-) astrocytes. Chemokine levels were greater in supernatants of IL-6 (+/+) astrocytes than IL-6 (-/-) cells prior to 48 h post-stimulation. At that time, higher levels of MIP-1 alpha. were maintained in IL-6 (+/+) supernatant, while similar levels of MCP-1 in supernatants of both IL-6 (+/+) and IL-6 (-/-) cells were measured. Additionally, LPS (100 ng/ml) resulted in greater levels of KC and Rantes in IL-6 (-/-) astrocyte supernatants compared with IL-6 (+/+) supernatants at that time. These results suggest that the autocrine modulatory activities of IL-6 affect multiple cytokine secretory pathways, which could participate in neurodegenerative processes. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:47 / 55
页数:9
相关论文
共 80 条
[1]  
ADERKA D, 1989, J IMMUNOL, V143, P3517
[2]  
Ajuebor MN, 1999, J IMMUNOL, V162, P1685
[3]  
ALOISI F, 1992, J IMMUNOL, V149, P2358
[4]   β-Amyloid-induced glial expression of both pro- and anti-inflammatory cytokines in cerebral cortex of aged transgenic Tg2576 mice with Alzheimer plaque pathology [J].
Apelt, J ;
Schliebs, R .
BRAIN RESEARCH, 2001, 894 (01) :21-30
[5]   Defective regulation of IFNγ and IL-12 by endogenous IL-10 in progressive MS [J].
Balashov, KE ;
Comabella, M ;
Ohashi, T ;
Khoury, SJ ;
Weiner, HL .
NEUROLOGY, 2000, 55 (02) :192-198
[6]   Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease [J].
Banati, RB ;
Daniel, SE ;
Blunt, SB .
MOVEMENT DISORDERS, 1998, 13 (02) :221-227
[7]   Induction of RANTES expression by astrocytes and astrocytoma cell lines [J].
Barnes, DA ;
Huston, M ;
Holmes, R ;
Benveniste, EN ;
Yong, VW ;
Scholz, P ;
Perez, HD .
JOURNAL OF NEUROIMMUNOLOGY, 1996, 71 (1-2) :207-214
[8]   Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients [J].
BlumDegen, D ;
Muller, T ;
Kuhn, W ;
Gerlach, M ;
Przuntek, H ;
Riederer, P .
NEUROSCIENCE LETTERS, 1995, 202 (1-2) :17-20
[9]   IMMUNOCYTOCHEMICAL ANALYSIS OF TUMOR-NECROSIS-FACTOR AND ITS RECEPTORS IN PARKINSONS-DISEASE [J].
BOKA, G ;
ANGLADE, P ;
WALLACH, D ;
JAVOYAGID, F ;
AGID, Y ;
HIRSCH, EC .
NEUROSCIENCE LETTERS, 1994, 172 (1-2) :151-154
[10]   Increased vulnerability of dopaminergic neurons in MPTP-lesioned interleukin-6 deficient mice [J].
Bolin, LM ;
Strycharska-Orczyk, I ;
Murray, R ;
Langston, JW ;
Di Monte, D .
JOURNAL OF NEUROCHEMISTRY, 2002, 83 (01) :167-175